Natural killing activities in chronic liver diseases and hepatocellular carcinoma

Journal of Clinical Immunology

Volumn 16, Issue 1, 1996, Pages 41-45

  Ono, Kazutoshi ^a,b   Yamanaga, Yoshiyuki ^a   Yamamoto, Kyousuke ^b   Koga, Shun Ichi ^a   Nishimura, Junji ^a   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Chronic active hepatitis; Chronic persistent hepatitis; Hepatocellular carcinoma; Liver cirrhosis; Natural killing activity

Indexed keywords

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; KILLER CELLS, NATURAL; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 0030053527     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01540971     Document Type: Article

References (22)

1. Ono K, Imazono Y, Misawa T, Nishimura J, Nawata H: Natural killing activity is associated with progression of gastric cancer. J Clin Immunol 15:210-214, 1995
2. Ono K, Shimamoto Y, Nishimura J, Yamaguchi M, Nawata H: A new analysis of natural killing activity and the role of monocytcs in normal subjects. J Clin Lab Immunol 30:175-181, 1989
3. Pross HF, Baines MG, Rubin P, Shragge P, Patterson MS: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol 1:51-63, 1981
4. Child CG: The Liver and Portal Hypertension. MPCS. Philadelphia, WB Saunders, 1964, p 50
5. Hermanek P, Sobin LH: TNM Classification of Malignant Tumors, 4th ed., UICC. Geneva, Springer Verlag, 1987
6. Hirai N, Kato Y, Kobayashi K, Hattori N: Natural killer (NK) cell activity and its in vitro response to interferon-alpha (Le) in chronic liver diseases and hepatocellular carcinoma. Liver 6:212-220, 1986
7. Koo JY, Park HC, Chung JM: Immunological studies in patients with HBsAg-positive hepatitis - Spontaneous lymphocyte transformation and natural killer cell activity. Korean J Intern Med 2:221-226, 1987
8. Takagi H, Sakurai S, Uehara M, Yamada S, Kobayashi S: NK activity in various liver diseases - especially the relation between NK activity and reverse function of the liver in liver cirrhosis and hepatocellular carcinoma. J Jpn Soc Cancer Ther 24:2369-2374, 1989
9. Par A, Szekeres-Bartho J, Pacsa S, Javor T: Effect of cianidanol on natural killer activity in patients with chronic B virus hepatitis. Int J Clin Pharmacol Res 7:301-306, 1987
10. Actis GC, Ponzetto A, D'urso N, Saracco G, Crepaldi T, Bellone G, Catucci LM, Zarcone D, Verme G: Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid. Liver 11:106-113, 1991
11. Wada T, Arima T, Nagashima H: Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin. Gastroenterol Jpn 22:312-321, 1987
12. Chuang WL, Liu HW, Chang WY, Chen SC, Hsieh MY, Wang LY: Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage. Dig Dis Sci 36:299-302, 1991
13. Govindarajan S, Fong TL, Valinluck B, Edwards V, Redeker AG: Markers of viral replication in patients with chronic hepatitis B virus infection. Am J Clin Pathol 89:233-337, 1988
14. Mills CT, Lee E, Perrillo R: Relationship between histology, aminotransferase levels, and viral replication in chronic hepatitis B. Gastroenterology 99:519-524, 1990
15. Dudley FJ, Fox RA, Sherlock S: Cellular immunity and hepatitis-associated (Australia) antigen liver disease. Lancet 1:723-726, 1972
16. Montano L, Aranguibel F, Boffill M, Goodall AH, Janossy G, Thomas HC: An analysis of the composition of the inflammatory infiltrate in autoimmune and hepatitis B virus-induced chronic liver disease. Hepatology 3:292-296, 1983
17. Chu CM, Shyu WC, Kuo RW, Liaw YF: HLA class 1 antigen display on hepatocyte membrane in chronic hepatitis B virus infection: Its role in the pathogenesis of chronic type B hepatitis. Hepatology 8:712-717, 1988
18. Nakamura T, Morizane T, Watanabe T, Tsuchimoto K, Inagaki Y, Kumagai N, Tsuchiya M: Decreased natural killer activity in patients with liver cirrhosis. Int J Cancer 32:573-575, 1983
19. Nakajima T, Mizushima N, Kanai K: Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver. Jpn J Clin Oncol 17:327-332, 1987
20. Hirofuji H, Kakumu S, Fuji A, Ohtani Y, Murase K, Tahara H: Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: Evidence for a decreased lymphokine-induced activity of effector cells. Clin Exp Immunol 68:348-356, 1987
21. Chu MH, Chien SC, Hu CP, Wang CY, Lee SD, Tsai YT, Wu JC, Han SH, Chang CM: Natural and activated cytotoxic lymphocytes reactivity to human hepatocellular carcinoma cell lines in hepatocellular carcinoma patients. Liver 8:198-207, 1988
22. Shirai M, Watanabe S, Nishioka M: Depressed lymphokine-activated killer activity and analysis of the precursor cells in peripheral blood of patients with hepatocellular carcinoma. Hepatogastroenterology 37:465-468, 1990